CLL Society in the News

CLL Society in the News

Medical and general news reports frequently feature CLL Society as a trusted information source and an authoritative voice of CLL patients’ concerns. When CLL Society surfaces in the news, we share it here.

FEATURED NEWS

February 2, 2023

USA Today Links the Immunocompromised to CLL Society’s COVID-19 Action Plan

In their 1/28/2023 article: Weak immune system? Government offers advice to help at-risk people avoid COVID-19 infections in the wake of the FDA’s withdrawal of Evusheld’s emergency authorization as it was ineffective for over 90% of the active SARS-CoV-2 variants of concerns, USA Today urges the immunocompromised to have a plan in place and links to CLL Society’s COVID-19 Action Plan as a helpful resource.

Read more.

November 14, 2022

Many Patients with Weak Immune Systems Don’t Realize Their COVID-19 Medicine Isn’t as Effective as It Used to Be

CNN interviewed CLL Society’s Dr. Brian Koffman and Robyn Brumble, RN, among others, to gain perspective on the significance of the diminishing susceptibility of the emerging SARS-CoV-2 Variants of Concern (VOC) to Evusheld. Evusheld is the only Pre-Exposure Prophylaxis (PrEP) available for the immunocompromised, which includes all of those with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

Read more.

ADDITIONAL READING

Dr. Koffman was interviewed by Prevention magazine to share some of his emotional experiences when he was diagnosed with chronic lymphocytic leukemia in 2005 and what he learned that helped him cope, primarily through the early part of his journey when he was asked to “Watch and Wait.” The
CNN interviewed CLL Society’s Dr. Brian Koffman and Robyn Brumble, RN, among others, to gain perspective on the significance of the diminishing susceptibility of the emerging SARS-CoV-2 Variants of Concern (VOC) to Evusheld, the only Pre-Exposure Prophylaxis (PrEP) for the immunocompromised; including all those with chronic lymphocytic leukemia/small lymphocytic